{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:52:09Z","timestamp":1792453929494,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Reproductive hormones of the fertile window are often referenced to women in regular cycles, but this may not be representative of the hormonal profiles of women in different circumstances like polycystic ovarian syndrome, the postpartum period, and the perimenopause transition. This observational cohort study sought to identify the variability in the reproductive hormones in various clinical circumstances and to establish potential thresholds for each category based on hormone measurements with the Mira urinary hormone monitor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 57 women (ages 22\u201351) in various circumstances (regular cycles, polycystic ovarian syndrome, postpartum and perimenopause) tracked Mira urine hormone measurements (estrone-3-glucuronide, luteinizing hormone, pregnanediol glucuronide), contributing 444 cycles of data. Using additive mixed models, hormone values were stratified by the four different reproductive categories. The perimenopause and polycystic ovarian syndrome groups demonstrated relative hypoestrogenic states, while the perimenopause group showed low luteal pregnanediol glucuronide and the polycystic ovarian syndrome\/polyendocrine metabolic ovarian syndrome (PCOS\/PMOS) group showed high luteal pregnanediol glucuronide. The perimenopause group had significantly higher luteinizing hormone values throughout the whole cycle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The fertile window hormone thresholds vary depending on a woman\u2019s specific reproductive category. Women in different circumstances should not necessarily use the same hormonal thresholds for the fertile window and ovulation. A larger dataset with ultrasound correlation to ovulation is required to delineate the fertile window with more precision. Hormone differences across the menstrual cycle could be used for targeted treatments in polycystic ovarian syndrome and perimenopause women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-026-02184-w","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:32:16Z","timestamp":1783920736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modeling fertile window differences across the reproductive lifespan with quantitative urine hormone monitoring of the menstrual cycle"],"prefix":"10.1186","volume":"19","author":[{"given":"Thomas P.","family":"Bouchard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Fehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Stujenske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Boychuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Schweinsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"2184_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2024.05.028","author":"SC Cromack","year":"2024","unstructured":"Cromack SC, Walter JR. Consumer wearables and personal devices for tracking the fertile window. Am J Obstet Gynecol. 2024. https:\/\/doi.org\/10.1016\/j.ajog.2024.05.028.","journal-title":"Am J Obstet Gynecol"},{"key":"2184_CR2","doi-asserted-by":"publisher","first-page":"e45139","DOI":"10.2196\/45139","volume":"26","author":"L Lyzwinski","year":"2024","unstructured":"Lyzwinski L, Elgendi M, Menon C. Innovative Approaches to Menstruation and Fertility Tracking Using Wearable Reproductive Health Technology: Systematic Review. J M\u00e9d Internet Res. 2024;26:e45139. https:\/\/doi.org\/10.2196\/45139.","journal-title":"J M\u00e9d Internet Res"},{"key":"2184_CR3","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/medicina59091513","volume":"59","author":"T Bouchard","year":"2023","unstructured":"Bouchard T, Yong P, Doyle-Baker P. Establishing a Gold Standard for Quantitative Menstrual Cycle Monitoring. Medicina. 2023;59:1513. https:\/\/doi.org\/10.3390\/medicina59091513.","journal-title":"Medicina"},{"key":"2184_CR4","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.3390\/medicina59112008","volume":"59","author":"TP Bouchard","year":"2023","unstructured":"Bouchard TP, Schweinsberg K, Smith A, Schneider M. Using Quantitative Hormone Monitoring to Identify the Postpartum Return of Fertility. Medicina. 2023;59:2008. https:\/\/doi.org\/10.3390\/medicina59112008.","journal-title":"Medicina"},{"key":"2184_CR5","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/medicina59101743","volume":"59","author":"M Meyers","year":"2023","unstructured":"Meyers M, Fehring RJ, Schneider M. Case Reports from Women Using a Quantitative Hormone Monitor to Track the Perimenopause Transition. Medicina. 2023;59:1743. https:\/\/doi.org\/10.3390\/medicina59101743.","journal-title":"Medicina"},{"key":"2184_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(26)00717-8","author":"HJ Teede","year":"2026","unstructured":"Teede HJ, Khomami MB, Morman R, Laven JSE, Joham AE, Costello MF, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026. https:\/\/doi.org\/10.1016\/s0140-6736(26)00717-8.","journal-title":"Lancet"},{"key":"2184_CR7","doi-asserted-by":"publisher","unstructured":"Malliou-Becher M-N, Herrmann PM, Freis A, Freundl-Sch\u00fctt T, Wallwiener L-M, Baur S, et al. Variations in ovulation time and menstrual cycle characteristics: analysis of a prospective long-term cohort study. Hum Reprod. 2026;deag057. https:\/\/doi.org\/10.1093\/humrep\/deag057.","DOI":"10.1093\/humrep\/deag057"},{"key":"2184_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/healthcare11040616","volume":"11","author":"AM Kici\u0144ska","year":"2023","unstructured":"Kici\u0144ska AM, Stachowska A, Kajdy A, Wierzba TH, Maksym RB. Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome\u2014Case Report. Healthcare. 2023;11:616. https:\/\/doi.org\/10.3390\/healthcare11040616.","journal-title":"Healthcare"},{"key":"2184_CR9","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1007\/s43032-021-00754-5","volume":"29","author":"RJ Hart","year":"2022","unstructured":"Hart RJ, D\u2019Hooghe T, Dancet EAF, Aurell R, Lunenfeld B, Orvieto R, et al. Self-Monitoring of Urinary Hormones in Combination with Telemedicine \u2014 a Timely Review and Opinion Piece in Medically Assisted Reproduction. Reprod Sci. 2022;29:3147\u201360. https:\/\/doi.org\/10.1007\/s43032-021-00754-5.","journal-title":"Reprod Sci"},{"key":"2184_CR10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1080\/14737159.2021.2000393","volume":"21","author":"TP Bouchard","year":"2021","unstructured":"Bouchard TP, Fehring RJ, Mu Q. Quantitative Versus Qualitative Estrogen and Luteinizing Hormone Testing for Personal Fertility Monitoring. Expert Rev Mol Diagn. 2021;21:1349\u201360. https:\/\/doi.org\/10.1080\/14737159.2021.2000393.","journal-title":"Expert Rev Mol Diagn"},{"key":"2184_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.xfre.2023.01.006","volume":"4","author":"GS Nakhuda","year":"2023","unstructured":"Nakhuda GS, Li N, Yang Z, Kang S. At-home urine estrone-3-glucuronide quantification predicts oocyte retrieval outcomes comparably with serum estradiol. F S Rep. 2023;4:43\u20138. https:\/\/doi.org\/10.1016\/j.xfre.2023.01.006.","journal-title":"F S Rep"},{"key":"2184_CR12","doi-asserted-by":"publisher","first-page":"105660","DOI":"10.1016\/j.rbmo.2026.105660","volume":"53","author":"TP Bouchard","year":"2026","unstructured":"Bouchard TP, Pierson R, Ecochard R, Lane M, Alger GE, Diment CJ, et al. Using corpus luteum formation with dominant follicle collapse to improve the criteria for identifying ovulation. Reprod Biomed Online. 2026;53:105660. https:\/\/doi.org\/10.1016\/j.rbmo.2026.105660.","journal-title":"Reprod Biomed Online"},{"key":"2184_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.fertnstert.2012.08.047","volume":"99","author":"A Direito","year":"2013","unstructured":"Direito A, Bailly S, Mariani A, Ecochard R. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women. Fertil Steril. 2013;99:279\u201385. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.08.047.","journal-title":"Fertil Steril"},{"key":"2184_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.fertnstert.2017.05.012","volume":"108","author":"R Ecochard","year":"2017","unstructured":"Ecochard R, Bouchard T, Leiva R, Abdulla S, Dupuis O, Duterque O, et al. Characterization of hormonal profiles during the luteal phase in regularly menstruating women. Fertil Steril. 2017;108:175\u2013e1821. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.05.012.","journal-title":"Fertil Steril"},{"key":"2184_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13625187.2015.1048331","volume":"20","author":"J Roos","year":"2015","unstructured":"Roos J, Johnson S, Weddell S, Godehardt E, Schiffner J, Freundl G, et al. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation. Eur J Contracept reproductive health care: official J Eur Soc Contracept. 2015;20:1\u201313. https:\/\/doi.org\/10.3109\/13625187.2015.1048331.","journal-title":"Eur J Contracept reproductive health care: official J Eur Soc Contracept"},{"key":"2184_CR16","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3390\/medicina59071348","volume":"59","author":"E Hills","year":"2023","unstructured":"Hills E, Woodland MB, Divaraniya A. Using Hormone Data and Age to Pinpoint Cycle Day within the Menstrual Cycle. Medicina. 2023;59:1348. https:\/\/doi.org\/10.3390\/medicina59071348.","journal-title":"Medicina"},{"key":"2184_CR17","doi-asserted-by":"publisher","first-page":"hoac058","DOI":"10.1093\/hropen\/hoac058","volume":"2023","author":"S Pattnaik","year":"2022","unstructured":"Pattnaik S, Das D, Venkatesan VA, Rai A. Predicting serum hormone concentration by estimation of urinary hormones through a home-use device. Hum Reprod Open. 2022;2023:hoac058. https:\/\/doi.org\/10.1093\/hropen\/hoac058.","journal-title":"Hum Reprod Open"},{"key":"2184_CR18","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3390\/medicina58121853","volume":"58","author":"AK Wegrzynowicz","year":"2022","unstructured":"Wegrzynowicz AK, Beckley A, Eyvazzadeh A, Levy G, Park J, Klein J. Complete Cycle Mapping Using a Quantitative At-Home Hormone Monitoring System in Prediction of Fertile Days, Confirmation of Ovulation, and Screening for Ovulation Issues Preventing Conception. Medicina. 2022;58:1853. https:\/\/doi.org\/10.3390\/medicina58121853.","journal-title":"Medicina"},{"key":"2184_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/humrep\/dew287","volume":"32","author":"R Wang","year":"2016","unstructured":"Wang R, Mol BWJ. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? Hum Reprod. 2016;32:261\u20134. https:\/\/doi.org\/10.1093\/humrep\/dew287.","journal-title":"Hum Reprod"},{"key":"2184_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/ijms23010512","volume":"23","author":"S Chauvin","year":"2022","unstructured":"Chauvin S, Cohen-Tannoudji J, Guigon CJ. Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies. Int J Mol Sci. 2022;23:512. https:\/\/doi.org\/10.3390\/ijms23010512.","journal-title":"Int J Mol Sci"},{"key":"2184_CR21","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1210\/jcem.82.11.4377","volume":"82","author":"A Arroyo","year":"1997","unstructured":"Arroyo A, Laughlin GA, Morales AJ, Yen SSC. Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity1. J Clin Endocrinol Metab. 1997;82:3728\u201333. https:\/\/doi.org\/10.1210\/jcem.82.11.4377.","journal-title":"J Clin Endocrinol Metab"},{"key":"2184_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/0024363918809698","volume":"85","author":"T Bouchard","year":"2018","unstructured":"Bouchard T, Blackwell L, Brown S, Fehring R, Parenteau-Carreau S. Dissociation between Cervical Mucus and Urinary Hormones during the Postpartum Return of Fertility in Breastfeeding Women. Linacre Q. 2018;85:399\u2013411. https:\/\/doi.org\/10.1177\/0024363918809698.","journal-title":"Linacre Q"},{"key":"2184_CR23","doi-asserted-by":"publisher","unstructured":"Schneider MM, Fehring RJ, Bouchard TP. Effectiveness of a Postpartum Breastfeeding Protocol for Avoiding Pregnancy. Linacre Q. 2023;002436392311672. https:\/\/doi.org\/10.1177\/00243639231167235.","DOI":"10.1177\/00243639231167235"},{"key":"2184_CR24","doi-asserted-by":"crossref","unstructured":"Fehring R, Barron M, Schneider M. Protocol for determining fertility while breastfeeding and not in cycles. Fertility and Sterility. 2005;84:805\u20137. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16366404905934012477.","DOI":"10.1016\/j.fertnstert.2005.03.042"},{"key":"2184_CR25","doi-asserted-by":"crossref","unstructured":"Bouchard TP, Doyle-Baker PK, Yong PJ, Fehring RJ, Schneider M. Validating At-Home Urinary Hormone Measurements in Postpartum and Perimenopause Fertility Transitions. Women\u2019s Health Reports. 2024.","DOI":"10.1089\/whr.2024.0157"},{"key":"2184_CR26","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/gme.0000000000001424","volume":"26","author":"SRE Khoudary","year":"2019","unstructured":"Khoudary SRE, Greendale G, Crawford SL, Avis NE, Brooks MM, Thurston RC, et al. The menopause transition and women\u2019s health at midlife: a progress report from the Study of Women\u2019s Health Across the Nation (SWAN). Menopause (N York Ny). 2019;26:1213\u201327. https:\/\/doi.org\/10.1097\/gme.0000000000001424.","journal-title":"Menopause (N York Ny)"},{"key":"2184_CR27","doi-asserted-by":"publisher","unstructured":"Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10. Menopause. 2012;19:387\u201395. https:\/\/doi.org\/10.1097\/gme.0b013e31824d8f40.","DOI":"10.1097\/gme.0b013e31824d8f40"},{"key":"2184_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ajog.2012.01.046","volume":"207","author":"MG Munro","year":"2012","unstructured":"Munro MG, Critchley HOD, Fraser IS. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? Am J Obstet Gynecol. 2012;207:259\u201365. https:\/\/doi.org\/10.1016\/j.ajog.2012.01.046.","journal-title":"Am J Obstet Gynecol"},{"key":"2184_CR29","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/humrep\/14.7.1835","volume":"14","author":"DB Dunson","year":"1999","unstructured":"Dunson DB, Baird DD, Wilcox AJ, Weinberg CR. Day-specific probabilities of clinical pregnancy based on two studies with imperfect measures of ovulation. Hum Reprod. 1999;14:1835\u20139. https:\/\/doi.org\/10.1093\/humrep\/14.7.1835.","journal-title":"Hum Reprod"},{"key":"2184_CR30","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3390\/medicina59091509","volume":"59","author":"TM Stujenske","year":"2023","unstructured":"Stujenske TM, Mu Q, Capotosto MP, Bouchard TP. Survey Analysis of Quantitative and Qualitative Menstrual Cycle Tracking Technologies. Medicina. 2023;59:1509. https:\/\/doi.org\/10.3390\/medicina59091509.","journal-title":"Medicina"},{"key":"2184_CR31","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/gme.0000000000000895","volume":"24","author":"RJ Turner","year":"2017","unstructured":"Turner RJ, Kerber IJ. A theory of eu-estrogenemia. Menopause. 2017;24:1086\u201397. https:\/\/doi.org\/10.1097\/gme.0000000000000895.","journal-title":"Menopause"},{"key":"2184_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/gme.0b013e31817ee0c2","volume":"16","author":"GE Hale","year":"2009","unstructured":"Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition. Menopause. 2009;16:50\u20139. https:\/\/doi.org\/10.1097\/gme.0b013e31817ee0c2.","journal-title":"Menopause"},{"key":"2184_CR33","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1097\/gme.0b013e3181aa192d","volume":"16","author":"KA O\u2019Connor","year":"2009","unstructured":"O\u2019Connor KA, Ferrell R, Brindle E, Trumble B, Shofer J, Holman DJ, et al. Progesterone and ovulation across stages of the transition to menopause. Menopause. 2009;16:1178\u201387. https:\/\/doi.org\/10.1097\/gme.0b013e3181aa192d.","journal-title":"Menopause"},{"key":"2184_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.fertnstert.2014.03.034","volume":"102","author":"R Ecochard","year":"2014","unstructured":"Ecochard R, Guillerm A, Leiva R, Bouchard T, Direito A, Boehringer H. Characterization of follicle stimulating hormone profiles in normal ovulating women. Fertil Steril. 2014;102:237\u2013e2435. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.03.034.","journal-title":"Fertil Steril"},{"key":"2184_CR35","doi-asserted-by":"publisher","unstructured":"Abdullah S, Bouchard T, Leiva R, Boehringer H, Iwaz J, Ecochard R. Distinct urinary progesterone metabolite profiles during the luteal phase. Hormone Mol Biology Clin Invest. 2022;0. https:\/\/doi.org\/10.1515\/hmbci-2022-0065.","DOI":"10.1515\/hmbci-2022-0065"},{"key":"2184_CR36","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1515\/cclm-2014-1087","volume":"0","author":"S Johnson","year":"2015","unstructured":"Johnson S, Weddell S, Godbert S, Freundl G, Roos J, Gnoth C. Development of the first urinary reproductive hormone ranges referenced to independently determined ovulation day. Clinical chemistry and laboratory medicine: CCLM \/. FESCC. 2015;0:1099\u2013108. https:\/\/doi.org\/10.1515\/cclm-2014-1087.","journal-title":"FESCC"},{"key":"2184_CR37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jogc.2019.09.023","volume":"42","author":"R Zwingerman","year":"2020","unstructured":"Zwingerman R, Chaikof M, Jones C. A Critical Appraisal of Fertility and Menstrual Tracking Apps for the iPhone. J Obstet Gynaecol Can. 2020;42:583\u201390. https:\/\/doi.org\/10.1016\/j.jogc.2019.09.023.","journal-title":"J Obstet Gynaecol Can"},{"key":"2184_CR38","doi-asserted-by":"publisher","unstructured":"Yong PJ, Khan Z, Wahl K, Bouchard TP, Doyle-Baker PK, Prior JC. Menstrual Health Literacy, Equity and Research Priorities. J Obstet Gynaecol Can. 2024;46:102-104 . https:\/\/doi.org\/10.1016\/j.jogc.2024.102711","DOI":"10.1016\/j.jogc.2024.102711"},{"key":"2184_CR39","unstructured":"Clearblue Menopause Stage Indicator. https:\/\/www.clearblue.com\/healthcare-professionals\/menopause\/stage-indicator . Cited 2024 Dec 12. Accessed 12 Dec 2024."},{"key":"2184_CR40","doi-asserted-by":"crossref","unstructured":"Bouchard TP, Bedaiwy M, Talhouk A, Nakhuda G, Yong PJ, Doyle-Baker PK. Mira urine hormone monitor validation for ovulation prediction and confirmation: blinded comparison with ultrasound and serum hormonesValidating ovulation prediction and confirmation with the Mira monitor: blinded ultrasound and serum hormone comparison. RBMO 2026 (in press).","DOI":"10.1016\/j.rbmo.2026.105881"},{"key":"2184_CR41","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.steroids.2013.06.006","volume":"78","author":"R Ecochard","year":"2013","unstructured":"Ecochard R, Leiva R, Bouchard T, Boehringer H, Direito A, Mariani A, et al. Use of urinary pregnanediol 3-glucuronide to confirm ovulation. Steroids. 2013;78:1035\u201340. https:\/\/doi.org\/10.1016\/j.steroids.2013.06.006.","journal-title":"Steroids"},{"key":"2184_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.steroids.2015.06.013","volume":"101","author":"R Leiva","year":"2015","unstructured":"Leiva R, Bouchard T, Boehringer H, Abulla S, Ecochard R. Random serum progesterone threshold to confirm ovulation. Steroids. 2015;101:125\u20139. https:\/\/doi.org\/10.1016\/j.steroids.2015.06.013.","journal-title":"Steroids"},{"key":"2184_CR43","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/uog.1891","volume":"25","author":"AR Baerwald","year":"2005","unstructured":"Baerwald AR, Adams GP, Pierson RA. Form and function of the corpus luteum during the human menstrual cycle. Ultrasound Obstet Gynecol. 2005;25:498\u2013507. https:\/\/doi.org\/10.1002\/uog.1891.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2184_CR44","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1590\/s0100-879x2004000500015","volume":"37","author":"HC Mendon\u00e7a","year":"2004","unstructured":"Mendon\u00e7a HC, Montenegro RM, Montenegro RM, Foss MC, de S\u00e1 MFS, Ferriani RA. Positive correlation of serum leptin with estradiol levels in patients with polycystic ovary syndrome. Braz J M\u00e9d Biol Res. 2004;37:729\u201336. https:\/\/doi.org\/10.1590\/s0100-879x2004000500015.","journal-title":"Braz J M\u00e9d Biol Res"},{"key":"2184_CR45","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s10815-020-01865-9","volume":"37","author":"MS Lee","year":"2020","unstructured":"Lee MS, Lanes A, Dolinko AV, Bailin A, Ginsburg E. The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone. J Assist Reprod Genet. 2020;37:2293\u2013304. https:\/\/doi.org\/10.1007\/s10815-020-01865-9.","journal-title":"J Assist Reprod Genet"},{"key":"2184_CR46","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1126\/science.2343313","volume":"248","author":"C Djerassi","year":"1990","unstructured":"Djerassi C. Fertility awareness: jet-age rhythm method? Science. 1990;248:1061\u20132.","journal-title":"Science"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02184-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02184-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02184-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:21:53Z","timestamp":1791847313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02184-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2184"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02184-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6669318\/v1","asserted-by":"object"}]},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Every participant provided their consent to participate. The study was approved by the Marquette University research ethics board (HR 4276, April 4, 2023).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TPB\u2019s PhD studies are sponsored by a University of Calgary Mitacs grant co-sponsored by Quanovate Tech, developers of the Mira urine hormone fertility monitor. The remaining authors report no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"313"}}